Clinical Relevance of Pretransplant HLA Class II Donor-specific Antibodies in Renal Transplantation Patients with Negative T-cell Cytotoxicity Crossmatches

Documenti analoghi

• Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches
  di: Johan Noble, et al.
  Pubblicazione: (2025-06-01)
• Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients
  di: Morrison, Alexander H., et al.
  Pubblicazione: (2019)
• Causes of Positive Pretransplant Crossmatches in the Absence of Donor-Specific Anti-Human Leukocyte Antigen Antibodies: A Single-Center Experience
  di: Kang, Hyunhye, et al.
  Pubblicazione: (2021)
• The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation
  di: Yang, Shin-Seok, et al.
  Pubblicazione: (2017)
• THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS
  di: Takaya, Shunichi, et al.
  Pubblicazione: (1992)